Post-approval studies (Phase 4)WithdrawnNCT03737617
What this trial is testing
Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis
Who this might be right for
BronchiectasisImmunoglobulin Subclass Deficiency
University of Edinburgh